مواقع التدريسيينجامعة الكوفة
أحمد كريم حسين مبارك
أستاذ مساعد

أحمد كريم حسين مبارك

English Version
0بحث منشور
0محاضرة
0اهتمام بحثي
0خبر

الملف الشخصي

خريج كلية الصيدلة جامعة الكوفة 2007 الثاني على الدورة وعملت معيدا في كليتي في مختلف الاقسام العلمية وتم اكمال اقامتي في مدينة الصدر الطبية ثم التحقت بجامعة بغداد لدراسة الماجستير الكيمياء الصيدلانية واكملت فى2013 م وعملت كتدريسي في كلية الصيدلة جامعة الكوفة

الاهتمامات البحثية

4

البحوث المنشورة

8
2020

DESIGN, SYNTHESIS AND ANTIBACTERIAL STUDY OF NEW GATIFLXACIN-ANTIOXIDANTS AS MUTUAL PRODRUG

الباحثونNoor H. Nasser، Sahar A. Hussein, Ahmed K. Hussein, Ammar A. Alibeg, Zainab M. Jasim
المجلة Journal Of Biochemical Technology
مختصر البحث

Abstract Objective: The objective of this search is to design, and synthesize new mutual prodrugs in order to obtain synergistic antibacterial activity. Methods: The hydroxyl group of three antioxidants (menthol, thymol, and vanillin), was linked to chloroacetyl chloride through nucleophilic substitution reaction, to give intermediates (Ia-Ic), which were reacted with a carboxyl group of Gatifloxacin to form three final compounds (I-III) having ester linkage. Results: The Antibacterial activity effect of the target compounds (I-III) has been tested for in vitro inhibitory activity against Gram-positive bacteria: Staphylococcus aureus and Gram-negative bacteria: Escherichia coli by using spots diffusion method. All the tested compounds show a remarkable antibacterial activity against tested bacteria. Conclusion: The synthesized prodrugs were characterized and identified through FT-IR spectroscopy, 1H-NMR spectrum, and various physicochemical parameters. The antibacterial study of the compounds showed various activities toward the two types of pathogenic bacteria which are Staphylococcus aureus and Escherichia coli. Compounds [I, II, and III] revealed that Staphylococcus aureus was sensitive to synthesized compounds but Escherichia coli showed a reverse activity with some resistance for antibacterial drugs.

2020

Design and Synthesis of Sulindac New Derivitives as Possible Mutual Prodrug with Potential to Maximized Therapeutic Area

الباحثون Ahmed Kareem Hussein Mubarak1 ، , Ahmed Wheed Radhi Alhasnaway1 , Haider F.S.Al-zubai
المجلة1956 Indian Journal of Forensic Medicine & Toxicology, July-September 2021, Vol. 15, No. 3
مختصر البحث

Drug design to enhance Therapeutic action of sulindac

2018

DESIGN ,SYNTHESIS OF CYTARABINE NEW DERIVITIVES AS POSSIPLE AN IMINE PRODRUG WITH POTENTIAL TO IMPROVE THERAPEUTIC CRITERIA

الباحثونAHMED KAREEM HUSSEIN، NO OTHER
المجلةResearch Journal of Pharmacy and Technology
مختصر البحث

Anti metabolite cytarabine is fantastic molecule posses both of most important therapeutic action anti neoplastic and anti viralagent. Today the both of anti cancer and anti viral agent sharing the same therapeutic problems which limit their therapeutic pharmacological biological action which are (the resistance and the cytotoxicity and poor pharmacokinetics parameters). In our project we do the pharmaceutical chemical modifications on the cytarabine as nucleus and targeting amino functionality to design and synthesis the number of new derivatives in light of an pharmaceutical amino group prodrug modification strategies an imine formation to improve therapeutic action (antineoplastic and antiviral action), expected to explore new biological actionand to minimized the emergent resistance, cytotoxicity and expected to improve kinetics of cytarabine.

2018

Synthesis and Antibacterial Evaluation of new Ofloxacin-Chalcone derivatives Conjugates as Possible Mutual Prodrugs

الباحثونDr./Mr(s). Samer A. Hasan/ University of Kufa, IRAQ ، Dr./Mr(s). Samer A. Hasan/ University of Kufa, IRAQ Dr./Mr(s). Noor H. Nasser/ University of Kufa, IRAQ Dr./Mr(s). Ahmed K. Hussein/ University of Kufa, IRAQ Dr./Mr(s). Abbas H. Abdulsada/ University of Babylon, IRAQ Dr./Mr(s). Zainab M. Jasim/ University of Kufa, IRAQ Dr./Mr(s). Sarah H. Shaalan/ University of Kufa, IRAQ Dr./Mr(s). Hawraa K. Musai/ University of Kufa, IRAQ
المجلةJournal of Pharmaceutical Sciences and Research
مختصر البحث

design and synthesis of new analoges of Ofloxacin-Chalcone derivatives Conjugates to maximize the anti bacterial action

2016

Design, Synthesis, and characterization of a novel Ciprofloxacin-Antioxidant mutual prodrugs

الباحثونAhmed K. Hussein، Noor H. Nasser, Abbas H. Abdulsada and Samer A. Hasan
المجلةDer Pharma Chemica
مختصر البحث

ABSTRACT A novel Prodrugs (Compounds I and II) have been designed, and synthesized, in which ciprofloxacin has been linked to two different anti-oxidants using chloroacetylchloride as spacer. These prodrugs have been characterized by various physico-chemical methods like melting points, Rf values, and FT-IR spectrum. Keywords: Ciprofloxacin,

2015

DESIGN AND SYNTHESIS OF NEW DERIVATIVES OF KETOPROFEN LINKED TO NATURAL ANTIOXIDANTS (THYMOL, MENTHOL & GUAIACOL) AS POSSIBLE MUTUAL PRODRUGS

الباحثونDhurgham Q. Shaheed، Ahmed Kareem Hussein Mubarak*, Ammar Abdul Aziz libeg, Hayder Kadhium Abbas, Mohammed Dakhil ALRekabi, Ahmed Hashim Husssein
المجلةWorld Journal of Pharmaceutical Research
مختصر البحث

bstract Non-steroidal anti-inflammatory drugs (NSAIDs) represent one of the most widely used classes of drugs. They are used primarily for the treatment of osteoarthritis, rheumatoid arthritis and other inflammatory disorders. However, the use of NSAIDs is limited due to possibility of inducing erosions and ulcers in the gastrointestinal tract. Recently, it has been well established that generation of various reactive oxygen species (ROS) locally plays a significant role in the formation of gastric ulceration associated with NSAID therapy. Therefore, in the present study NSAIDs (ketoprofen) have been conjugated with different antioxidants (thymol, menthol and guaiacol) having anti ulcerogenic activity. The objective was to obtain Ketoprfen– antioxidant derivatives as possible mutual prodrug that includes: Ketoprofen-thymol (Compound I), Ketoprofen-menthol (Compound II) and Ketoprofen-guaiacol (Compound III). The mutual prodrug of NSAID and antioxidant was designated to generate the complementary pharmacological action as a single chemical entity with improved anti-inflammatory action and reduced ulcerogenic adverse effect. The synthesis is conferred by FT-IR, CHNS and physiochemical properties.

2015

DESIGN AND SYNTHESIS OF DICLOFENAC AND INDOMETHACIN – CONJUGATES WITH GEMCITABINE AS A POSSIBLE MUTUAL PRODRUGS

الباحثونDhurgham Q. Shaheed، Ahmed Kareem Hussein Mubarak*, Akeel Abdulkadium Jassim Aboalard, Hayder Kadhium Abbas, Mohammed Dakhil ALRekabi, and Ahmed Hashim Husssein
المجلةWorld Journal of Pharmaceutical Research
مختصر البحث

ABSTRACT Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed classes of drugs and their long-term regimens have been greatly shortened due to their gastrointestinal side effects. COX-2 plays a pivotal role throughout oncogenesis and here we exploit the rationale to explore the use of NSAID (Diclofenac and indomethacin) in combination with current anticancer drug (Gemcitabine) for the prevention and/or treatment of cancer. The study describes design and synthesis of mutual pro-drug of NSAID and gemicitabine, which is designated to generate the complementary pharmacological action as a single chemical entity with improved drug targeting. The synthesis is conferred by FT-IR, CHNS and physiochemical properties. The newly designed mutual pro-drug is expected to reduce the side effects of NSAIDs on the gastrointestinal (GI) tract with improvement of the oral bioavailability and targeting of gemcitabine.

2013

esign, Synthesis and Preliminary Pharmacological Evaluation of Mutual Prodrug of Non-Steroidal Anti-Inflammatory Drugs Coupling With Natural Anti-Oxidants Via Glycine

الباحثون Ahmed Kareem Hussein، Ashour H. Dawood Monther Faisal Mahdi
المجلةAl-Mustansiriyah Journal for Pharmaceutical Sciences
مختصر البحث

bstract Abstract:Non-steroidal anti-inflammatory drugs (NSAIDs); naproxen and indomethacin havebeen conjugated with different antioxidants (thymol, menthol & guaiacol) havingantiulcerogenic activity via glycine amino acid as spacer with the objective of obtainingNSAIDs-glycine- antioxidant prodrugs as gastrosparing NSAIDs devoid of ulcerogenic sideeffects and synergistically with anti-inflammatory action of glycine. Four mutual prodrugs (IIV)were synthesized using glycine as spacer and their structures were confirmed andcharacterized using elemental microanalysis (CHNO), IR, and some physiochemicalproperties.Invivo acute anti-inflammatory activity of the compounds (I & II) (naproxenderivatives) and the compounds (III & IV) (indomethacin derivatives) was evaluated in ratusing an egg-white induced edema model of inflammation in a dose equivalent to 2.5 mg/Kgof naproxen, and 2 mg/Kg of indomethacin respectively.All tested compounds produced significant reduction of paw edema with respect tothe effect of propylene glycol 50% v/v (control group). Moreover, the activity of compoundIII was significantly higher than that of indomethacin (at 2 mg/Kg), while compound IVexpressed a comparable effect to that of indomethacin in the (120–300) minute time of theexperiment, while compounds I&II was showed a comparable effect to that of naproxen at(180-300) minute time interval of the experiment. The result of this study indicates that thesemutual prodrugs of naproxen & indomethacin maintained or may enhanced their antiinflammatoryactivity. الخلاصة:الادویة المضادة للالتھاب غیر الستیرودیة (نابروكسین واندومیثاسین) تم أدماجھا مع مجموعة مختلفة من الموادالمضادة للاكسدة (الثیمول والمنثول وكوایاكول) الحاویة على نشاط مضاد للمقرحات باستخدام الحامض الامیني(الكلایسین) كذراع بھدف الحصول على مقدمات الأدویة المتبادلة لأدویة غیر ستیرویدیة مضادة للألتھاب مع أنواع مختلفةمن مضادات التأكسد بواسطة الحامضالامیني كأدویة غیر ستیرویدیة مضادة للألتھاب منقذة للمعدة تخلو من المقرح كأثارجانبیة مع زیادة فعالیتھا مع الكلایسین المتمیز بخواصھ المضادة للالتھابات.أربعة من مقدمات الأدویة المتبادلة تم تخلیقھا وتشخیص تركیبھا وخصائصھا باستخدام التحلیل الدقیق للعناصروبعضالخواصالفیزیوكیمیائیة. (IR) تحلیل طیف الأشعة تحت الحمراء ،(CHNO

المحاضرات

5

الأخبار والإعلانات

7
الأخبار 2020-11-18

FT-IR THEROY AND APPLICATIONS IN PHARMACEUTICAL RESEACH

ورشة الكترونية مباشر الموعد6-6-2020 الساعة ال5 مساء المعرف AHMEDKMUBAR :FCC

الأخبار 2020-11-18

ورشة الكترونية افتراضية حول التداخل الدوائي اساسيات وتطبيقات

المنصة الالكترونية لبرنامج الFCC

الأخبار 2020-11-18

ورشة الكترونية افتراضية

ON LINE ON FREE CALL CONFERANCE ID:AHMEDKMUBAR 3-6-2020 11A.M

الأخبار 2017-12-17

سمنار بعنوان استخدام الكومبيوتر في التصميم الدوائي 19-12-2017

اهمية الكومبيوتر في توفير بيئة افتراضية مرنة في تطوير وتصمييم المركبات الدوائية

الإعلانات 2017-04-09

دورة بعنوان التداخل الدوائي بين النظرية الصيدلانية و التطبيق السريري1-2018

اهمية التداخل الدوائي وكيفية التنبا به على المستويين الجزيئي و السريري وتحسين الجوانب الايجابية لتعزيز الاداء العلاجي الامثل وتقليل الاضرار السلبية الناجمة من التداخل الدوائي

الإعلانات 2017-01-10

دورة استخدام جهاز FTIRبين النظرية والتطبيق الصيدلاني

دورة مع ورشة عمل في 10-12-2017 في كلية الصيدلة جامعة الكوفة تطبيقات جهاز FTIR تفسير للطيف FTIR معايرة الجهاز كيفية تحضير عينات الدوائية للقياس بلجهاز تعليم حول برمجيات الجهاز تقييم للدورة

الأخبار 2017-01-10

سمنار في فرع الكيمياء الصيدلانية كلية الصيدلة جامعة الكوفة بعنوان (الادوية الغير ستيرودية المضادة للالتهاب اليوم وغدا)

الاربعاء11_1_2017 الساعة التاسعة والنصف صباحا حول تحضير مشتقات جديدة للادوية المضادة للالتهابات غير الستيرودية مع بعض المركبات الطبيعية لتحسين الفعالية وتقليل التاثيرات الجانبية والدعوة عامة للجميع

عرض التفاصيل